+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmaceutical Market in Canada 2024-2028

  • PDF Icon

    Report

  • 148 Pages
  • March 2024
  • Region: Canada
  • TechNavio
  • ID: 5949763
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical market in Canada is forecasted to grow by USD 8.73 bn during 2023-2028, accelerating at a CAGR of 4.6% during the forecast period. The report on the pharmaceutical market in Canada provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high investment in pharmaceutical industry, increasing geriatric population in Canada, and rising occurrence of chronic diseases in Canada.

The pharmaceutical market in Canada is segmented as below:

By Distribution Channel

  • Pharmacy
  • Clinic

By Type

  • Prescription
  • Non-prescription

By Therapy Area

  • Musculoskeletal system
  • Nervous system
  • Respiratory system
  • Others

By Geographical Landscape

  • North America
This study identifies the increasing advancements in biotechnology as one of the prime reasons driving the pharmaceutical market in Canada growth during the next few years. Also, digital health integration in pharmaceutical market in Canada and heightened focus on R and D for rare diseases will lead to sizable demand in the market.

The report on the pharmaceutical market in Canada covers the following areas:

  • Pharmaceutical market in Canada sizing
  • Pharmaceutical market in Canada forecast
  • Pharmaceutical market in Canada industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical market in Canada vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., Apotex Inc., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., LES LABORATOIRES SERVIER, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the pharmaceutical market in Canada analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 08: Parent market
Exhibit 09: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 10: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 11: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 12: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 13: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 14: Chart on Canada: Year-over-year growth 2023-2028 (%)
Exhibit 15: Data Table on Canada: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Pharmaceutical market in Canada 2018 - 2022
Exhibit 16: Historic Market Size - Data Table on pharmaceutical market in Canada 2018 - 2022 ($ billion)
4.2 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 17: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 18: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.4 Therapy Area Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Therapy Area Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 20: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 26: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 27: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 28: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 29: Chart on Comparison by Distribution Channel
Exhibit 30: Data Table on Comparison by Distribution Channel
6.3 Pharmacy - Market size and forecast 2023-2028
Exhibit 31: Chart on Pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 32: Data Table on Pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 33: Chart on Pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 34: Data Table on Pharmacy - Year-over-year growth 2023-2028 (%)
6.4 Clinic - Market size and forecast 2023-2028
Exhibit 35: Chart on Clinic - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Data Table on Clinic - Market size and forecast 2023-2028 ($ billion)
Exhibit 37: Chart on Clinic - Year-over-year growth 2023-2028 (%)
Exhibit 38: Data Table on Clinic - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Distribution Channel
Exhibit 39: Market opportunity by Distribution Channel ($ billion)
Exhibit 40: Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 41: Chart on Type - Market share 2023-2028 (%)
Exhibit 42: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 43: Chart on Comparison by Type
Exhibit 44: Data Table on Comparison by Type
7.3 Prescription - Market size and forecast 2023-2028
Exhibit 45: Chart on Prescription - Market size and forecast 2023-2028 ($ billion)
Exhibit 46: Data Table on Prescription - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Chart on Prescription - Year-over-year growth 2023-2028 (%)
Exhibit 48: Data Table on Prescription - Year-over-year growth 2023-2028 (%)
7.4 Non-prescription - Market size and forecast 2023-2028
Exhibit 49: Chart on Non-prescription - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Data Table on Non-prescription - Market size and forecast 2023-2028 ($ billion)
Exhibit 51: Chart on Non-prescription - Year-over-year growth 2023-2028 (%)
Exhibit 52: Data Table on Non-prescription - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Exhibit 53: Market opportunity by Type ($ billion)
Exhibit 54: Data Table on Market opportunity by Type ($ billion)
8 Market Segmentation by Therapy Area
8.1 Market segments
Exhibit 55: Chart on Therapy Area - Market share 2023-2028 (%)
Exhibit 56: Data Table on Therapy Area - Market share 2023-2028 (%)
8.2 Comparison by Therapy Area
Exhibit 57: Chart on Comparison by Therapy Area
Exhibit 58: Data Table on Comparison by Therapy Area
8.3 Musculoskeletal system - Market size and forecast 2023-2028
Exhibit 59: Chart on Musculoskeletal system - Market size and forecast 2023-2028 ($ billion)
Exhibit 60: Data Table on Musculoskeletal system - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Chart on Musculoskeletal system - Year-over-year growth 2023-2028 (%)
Exhibit 62: Data Table on Musculoskeletal system - Year-over-year growth 2023-2028 (%)
8.4 Nervous system - Market size and forecast 2023-2028
Exhibit 63: Chart on Nervous system - Market size and forecast 2023-2028 ($ billion)
Exhibit 64: Data Table on Nervous system - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Chart on Nervous system - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on Nervous system - Year-over-year growth 2023-2028 (%)
8.5 Respiratory system - Market size and forecast 2023-2028
Exhibit 67: Chart on Respiratory system - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on Respiratory system - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on Respiratory system - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Respiratory system - Year-over-year growth 2023-2028 (%)
8.6 Others - Market size and forecast 2023-2028
Exhibit 71: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Others - Year-over-year growth 2023-2028 (%)
8.7 Market opportunity by Therapy Area
Exhibit 75: Market opportunity by Therapy Area ($ billion)
Exhibit 76: Data Table on Market opportunity by Therapy Area ($ billion)
9 Customer Landscape
9.1 Customer landscape overview
Exhibit 77: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 78: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 79: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 80: Overview on factors of disruption
11.4 Industry risks
Exhibit 81: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 82: Vendors covered
12.2 Market positioning of vendors
Exhibit 83: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 84: Abbott Laboratories - Overview
Exhibit 85: Abbott Laboratories - Business segments
Exhibit 86: Abbott Laboratories - Key offerings
Exhibit 87: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 88: AbbVie Inc. - Overview
Exhibit 89: AbbVie Inc. - Product/Service
Exhibit 90: AbbVie Inc. - Key news
Exhibit 91: AbbVie Inc. - Key offerings
12.5 AstraZeneca PLC
Exhibit 92: AstraZeneca PLC - Overview
Exhibit 93: AstraZeneca PLC - Product/Service
Exhibit 94: AstraZeneca PLC - Key news
Exhibit 95: AstraZeneca PLC - Key offerings
12.6 Bayer AG
Exhibit 96: Bayer AG - Overview
Exhibit 97: Bayer AG - Business segments
Exhibit 98: Bayer AG - Key news
Exhibit 99: Bayer AG - Key offerings
Exhibit 100: Bayer AG - Segment focus
12.7 Boehringer Ingelheim International GmbH
Exhibit 101: Boehringer Ingelheim International GmbH - Overview
Exhibit 102: Boehringer Ingelheim International GmbH - Business segments
Exhibit 103: Boehringer Ingelheim International GmbH - Key news
Exhibit 104: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 105: Boehringer Ingelheim International GmbH - Segment focus
12.8 Bristol-Myers Squibb Company
Exhibit 106: Bristol-Myers Squibb Company - Overview
Exhibit 107: Bristol-Myers Squibb Company - Product/Service
Exhibit 108: Bristol-Myers Squibb Company - Key news
Exhibit 109: Bristol-Myers Squibb Company - Key offerings
12.9 Eli Lilly and Co.
Exhibit 110: Eli Lilly and Co. - Overview
Exhibit 111: Eli Lilly and Co. - Product/Service
Exhibit 112: Eli Lilly and Co. - Key news
Exhibit 113: Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann La Roche Ltd.
Exhibit 114: F. Hoffmann La Roche Ltd. - Overview
Exhibit 115: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 116: F. Hoffmann La Roche Ltd. - Key news
Exhibit 117: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 118: F. Hoffmann La Roche Ltd. - Segment focus
12.11 GlaxoSmithKline Plc
Exhibit 119: GlaxoSmithKline Plc - Overview
Exhibit 120: GlaxoSmithKline Plc - Business segments
Exhibit 121: GlaxoSmithKline Plc - Key news
Exhibit 122: GlaxoSmithKline Plc - Key offerings
Exhibit 123: GlaxoSmithKline Plc - Segment focus
12.12 Johnson and Johnson Services Inc.
Exhibit 124: Johnson and Johnson Services Inc. - Overview
Exhibit 125: Johnson and Johnson Services Inc. - Business segments
Exhibit 126: Johnson and Johnson Services Inc. - Key news
Exhibit 127: Johnson and Johnson Services Inc. - Key offerings
Exhibit 128: Johnson and Johnson Services Inc. - Segment focus
12.13 Merck and Co. Inc.
Exhibit 129: Merck and Co. Inc. - Overview
Exhibit 130: Merck and Co. Inc. - Business segments
Exhibit 131: Merck and Co. Inc. - Key news
Exhibit 132: Merck and Co. Inc. - Key offerings
Exhibit 133: Merck and Co. Inc. - Segment focus
12.14 Novartis AG
Exhibit 134: Novartis AG - Overview
Exhibit 135: Novartis AG - Business segments
Exhibit 136: Novartis AG - Key news
Exhibit 137: Novartis AG - Key offerings
Exhibit 138: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 139: Pfizer Inc. - Overview
Exhibit 140: Pfizer Inc. - Product/Service
Exhibit 141: Pfizer Inc. - Key news
Exhibit 142: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 143: Sanofi SA - Overview
Exhibit 144: Sanofi SA - Business segments
Exhibit 145: Sanofi SA - Key news
Exhibit 146: Sanofi SA - Key offerings
Exhibit 147: Sanofi SA - Segment focus
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 148: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 149: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 150: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 151: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 152: Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 153: Inclusions checklist
Exhibit 154: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 155: Currency conversion rates for US$
13.4 Research methodology
Exhibit 156: Research methodology
Exhibit 157: Validation techniques employed for market sizing
Exhibit 158: Information sources
13.5 List of abbreviations
Exhibit 159: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibits 7: Executive Summary - Chart on Vendor Market Positioning
Exhibits 8: Parent market
Exhibits 9: Market Characteristics
Exhibits 10: Offerings of vendors included in the market definition
Exhibits 11: Market segments
Exhibits 12: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 13: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 14: Chart on Canada: Year-over-year growth 2023-2028 (%)
Exhibits 15: Data Table on Canada: Year-over-year growth 2023-2028 (%)
Exhibits 16: Historic Market Size - Data Table on pharmaceutical market in Canada 2018 - 2022 ($ billion)
Exhibits 17: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits 18: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Therapy Area Segment 2018 - 2022 ($ billion)
Exhibits 20: Five forces analysis - Comparison between 2023 and 2028
Exhibits 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 23: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 24: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 25: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 26: Chart on Market condition - Five forces 2023 and 2028
Exhibits 27: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 28: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 29: Chart on Comparison by Distribution Channel
Exhibits 30: Data Table on Comparison by Distribution Channel
Exhibits 31: Chart on Pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits 32: Data Table on Pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits 33: Chart on Pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 34: Data Table on Pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 35: Chart on Clinic - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Data Table on Clinic - Market size and forecast 2023-2028 ($ billion)
Exhibits 37: Chart on Clinic - Year-over-year growth 2023-2028 (%)
Exhibits 38: Data Table on Clinic - Year-over-year growth 2023-2028 (%)
Exhibits 39: Market opportunity by Distribution Channel ($ billion)
Exhibits 40: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits 41: Chart on Type - Market share 2023-2028 (%)
Exhibits 42: Data Table on Type - Market share 2023-2028 (%)
Exhibits 43: Chart on Comparison by Type
Exhibits 44: Data Table on Comparison by Type
Exhibits 45: Chart on Prescription - Market size and forecast 2023-2028 ($ billion)
Exhibits 46: Data Table on Prescription - Market size and forecast 2023-2028 ($ billion)
Exhibits 47: Chart on Prescription - Year-over-year growth 2023-2028 (%)
Exhibits 48: Data Table on Prescription - Year-over-year growth 2023-2028 (%)
Exhibits 49: Chart on Non-prescription - Market size and forecast 2023-2028 ($ billion)
Exhibits 50: Data Table on Non-prescription - Market size and forecast 2023-2028 ($ billion)
Exhibits 51: Chart on Non-prescription - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on Non-prescription - Year-over-year growth 2023-2028 (%)
Exhibits 53: Market opportunity by Type ($ billion)
Exhibits 54: Data Table on Market opportunity by Type ($ billion)
Exhibits 55: Chart on Therapy Area - Market share 2023-2028 (%)
Exhibits 56: Data Table on Therapy Area - Market share 2023-2028 (%)
Exhibits 57: Chart on Comparison by Therapy Area
Exhibits 58: Data Table on Comparison by Therapy Area
Exhibits 59: Chart on Musculoskeletal system - Market size and forecast 2023-2028 ($ billion)
Exhibits 60: Data Table on Musculoskeletal system - Market size and forecast 2023-2028 ($ billion)
Exhibits 61: Chart on Musculoskeletal system - Year-over-year growth 2023-2028 (%)
Exhibits 62: Data Table on Musculoskeletal system - Year-over-year growth 2023-2028 (%)
Exhibits 63: Chart on Nervous system - Market size and forecast 2023-2028 ($ billion)
Exhibits 64: Data Table on Nervous system - Market size and forecast 2023-2028 ($ billion)
Exhibits 65: Chart on Nervous system - Year-over-year growth 2023-2028 (%)
Exhibits 66: Data Table on Nervous system - Year-over-year growth 2023-2028 (%)
Exhibits 67: Chart on Respiratory system - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Data Table on Respiratory system - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Chart on Respiratory system - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Respiratory system - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 75: Market opportunity by Therapy Area ($ billion)
Exhibits 76: Data Table on Market opportunity by Therapy Area ($ billion)
Exhibits 77: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 78: Impact of drivers and challenges in 2023 and 2028
Exhibits 79: Overview on Criticality of inputs and Factors of differentiation
Exhibits 80: Overview on factors of disruption
Exhibits 81: Impact of key risks on business
Exhibits 82: Vendors covered
Exhibits 83: Matrix on vendor position and classification
Exhibits 84: Abbott Laboratories - Overview
Exhibits 85: Abbott Laboratories - Business segments
Exhibits 86: Abbott Laboratories - Key offerings
Exhibits 87: Abbott Laboratories - Segment focus
Exhibits 88: AbbVie Inc. - Overview
Exhibits 89: AbbVie Inc. - Product/Service
Exhibits 90: AbbVie Inc. - Key news
Exhibits 91: AbbVie Inc. - Key offerings
Exhibits 92: AstraZeneca PLC - Overview
Exhibits 93: AstraZeneca PLC - Product/Service
Exhibits 94: AstraZeneca PLC - Key news
Exhibits 95: AstraZeneca PLC - Key offerings
Exhibits 96: Bayer AG - Overview
Exhibits 97: Bayer AG - Business segments
Exhibits 98: Bayer AG - Key news
Exhibits 99: Bayer AG - Key offerings
Exhibits 100: Bayer AG - Segment focus
Exhibits 101: Boehringer Ingelheim International GmbH - Overview
Exhibits 102: Boehringer Ingelheim International GmbH - Business segments
Exhibits 103: Boehringer Ingelheim International GmbH - Key news
Exhibits 104: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 105: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 106: Bristol-Myers Squibb Company - Overview
Exhibits 107: Bristol-Myers Squibb Company - Product/Service
Exhibits 108: Bristol-Myers Squibb Company - Key news
Exhibits 109: Bristol-Myers Squibb Company - Key offerings
Exhibits 110: Eli Lilly and Co. - Overview
Exhibits 111: Eli Lilly and Co. - Product/Service
Exhibits 112: Eli Lilly and Co. - Key news
Exhibits 113: Eli Lilly and Co. - Key offerings
Exhibits 114: F. Hoffmann La Roche Ltd. - Overview
Exhibits 115: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 116: F. Hoffmann La Roche Ltd. - Key news
Exhibits 117: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 118: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 119: GlaxoSmithKline Plc - Overview
Exhibits 120: GlaxoSmithKline Plc - Business segments
Exhibits 121: GlaxoSmithKline Plc - Key news
Exhibits 122: GlaxoSmithKline Plc - Key offerings
Exhibits 123: GlaxoSmithKline Plc - Segment focus
Exhibits 124: Johnson and Johnson Services Inc. - Overview
Exhibits 125: Johnson and Johnson Services Inc. - Business segments
Exhibits 126: Johnson and Johnson Services Inc. - Key news
Exhibits 127: Johnson and Johnson Services Inc. - Key offerings
Exhibits 128: Johnson and Johnson Services Inc. - Segment focus
Exhibits 129: Merck and Co. Inc. - Overview
Exhibits 130: Merck and Co. Inc. - Business segments
Exhibits 131: Merck and Co. Inc. - Key news
Exhibits 132: Merck and Co. Inc. - Key offerings
Exhibits 133: Merck and Co. Inc. - Segment focus
Exhibits 134: Novartis AG - Overview
Exhibits 135: Novartis AG - Business segments
Exhibits 136: Novartis AG - Key news
Exhibits 137: Novartis AG - Key offerings
Exhibits 138: Novartis AG - Segment focus
Exhibits 139: Pfizer Inc. - Overview
Exhibits 140: Pfizer Inc. - Product/Service
Exhibits 141: Pfizer Inc. - Key news
Exhibits 142: Pfizer Inc. - Key offerings
Exhibits 143: Sanofi SA - Overview
Exhibits 144: Sanofi SA - Business segments
Exhibits 145: Sanofi SA - Key news
Exhibits 146: Sanofi SA - Key offerings
Exhibits 147: Sanofi SA - Segment focus
Exhibits 148: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 149: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 150: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 151: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 152: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 153: Inclusions checklist
Exhibits 154: Exclusions checklist
Exhibits 155: Currency conversion rates for US$
Exhibits 156: Research methodology
Exhibits 157: Validation techniques employed for market sizing
Exhibits 158: Information sources
Exhibits 159: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the pharmaceutical market in Canada: Abbott Laboratories, AbbVie Inc., Amgen Inc., Apotex Inc., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., LES LABORATOIRES SERVIER, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing advancements in biotechnology.'

According to the report, one of the major drivers for this market is the high investment in pharmaceutical industry.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • Apotex Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • LES LABORATOIRES SERVIER
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.